Renal Dehydropeptidase Inhibitor [EPC] - N0000175514

Pharmacologic Code	N0000175514
Pharmacologic Name	Renal Dehydropeptidase Inhibitor
Pharmacologic Uses	renal dehydropeptidase inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Renal Dehydropeptidase Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0006-3516	Primaxin IV	Non-Proprietary Name: Imipenem And Cilastatin Sodium	Injection, Powder, For Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
	0006-3856	Recarbrio	Non-Proprietary Name: Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous	Injection, Powder, For Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
	44567-705	Imipenem And Cilastatin	Non-Proprietary Name: Imipenem And Cilastatin	Injection, Powder, For Solution	Intravenous	Wg Critical Care, Llc	ACTIVE
	63323-322	Imipenem And Cilastatin	Non-Proprietary Name: Imipenem And Cilastatin Sodium	Injection, Powder, For Solution	Intravenous	Fresenius Kabi Usa, Llc	ACTIVE
	63323-349	Imipenem And Cilastatin	Non-Proprietary Name: Imipenem And Cilastatin Sodium	Injection, Powder, For Solution	Intravenous	Fresenius Kabi Usa, Llc	ACTIVE